跳至主要内容
临床试验/NCT01298440
NCT01298440已完成不适用

The Effect of Intravitreal Bevacizumab (Avastin) Injection on Retinal Blood-Flow Velocity in Patients With Choroidal Neovascularization

Optical Imaging, Ltd.1 个研究点 分布在 1 个国家目标入组 12 人开始时间: 2008年1月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
12
试验地点
1
主要终点
Blood flow velocity change

研究概览

简要总结

Retinal blood flow velocity is affected by Bevacizump intravitreal injection. This effect is correlated to treatment success.

详细描述

The purpose of the study was to carry out a pilot study on the short-term effect of intravitreal Bevacizumab (Avastin) injection on retinal blood-flow velocity and test whether the short-term haemodynamic changes could predict the longer term clinical result of the treatment.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

性别
All
接受健康志愿者

入选标准

  • Patients with CNV receiving Bevacizumab intravitreal injection

排除标准

  • Candidates in whom the retina could not be seen clearly because of media opacity or a poorly dilating pupil

结局指标

主要结局

Blood flow velocity change

时间窗: 1 day following injection

次要结局

未报告次要终点

研究者

发起方
Optical Imaging, Ltd.
申办方类型
Industry

研究点 (1)

Loading locations...

相似试验